Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
arrhythmia; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. A 20-year-old female patient received BNT162b2 (BNT162B2), on 23Oct2021 as dose 2, single (Batch/Lot number: unknown) at the age of 20 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Peanut allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE , UNKNOWN MANUFACTURER), for Covid-19 Immunization. The following information was reported: ARRHYTHMIA (medically significant) with onset Oct2021, outcome "recovered" (Feb2022). Therapeutic measures were taken as a result of arrhythmia. Clinical course: Vaccine lot number provided as 301258A. Unknown if other vaccine same date, other vaccine in four weeks, other medications in two weeks. Patient stated that almost immediately after receiving the second dose she developed an arrhythmia. She had the arrhythmia for four months. She had to take a beta blocker and it eventually resolved. Treatment: Beta blocker. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Peanut allergy